Top compounds associated with response to ZNF229


Feature Type Standardized
Nominal ANOVA
mRNA BCL-LZH-4 CTRPv2 pan-cancer AAC -0.029 0.6
mRNA rigosertib CTRPv2 pan-cancer AAC -0.017 0.6
mRNA bendamustine CTRPv2 pan-cancer AAC -0.02 0.6
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.018 0.6
mRNA KX2-391 CTRPv2 pan-cancer AAC -0.017 0.6
mRNA Repligen 136 CTRPv2 pan-cancer AAC -0.019 0.6
mRNA CIL70 CTRPv2 pan-cancer AAC -0.024 0.6
mRNA MK-0752 CTRPv2 pan-cancer AAC 0.019 0.6
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.018 0.6
mRNA Panobinostat CTRPv2 pan-cancer AAC -0.017 0.6
Download CSV